The Food and Drug Administration has continued its pharma ad crackdown by issuing a pair of new Untitled Letters and releasing a series of close-out letters indicating drugmakers have made changes to ...

The FDA’s Office of Prescription Drug Promotion issued an Untitled Letter, backdated to September 23, to Tracey M. Henderson, MS, MBA – AstraZeneca’s promotional regulatory affairs review director, ...

The US Food and Drug Administration (FDA) has published scores of warning letters, most of them to companies for marketing and advertising compounded versions of glucagon-like peptide-1 (GLP-1) ...

PITTSFORD, N.Y. (WROC) – Less than one week until Election Day, a business owner in Pittsford says himself and others received an anonymous letter suggesting to not post political signs in front of ...

The US Food and Drug Administration (FDA) Office of Prescription Drug Promotion (OPDP) has issued its first two untitled letters of the year to two companies, Altor BioScience and BeOne Medicines ...